Isoketals form cytotoxic phosphatidylethanolamine adducts in cells

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 999-1009

  Sullivan, C Blake ^a   Matafonova, Elena ^a   Roberts II, L Jackson ^a   Amarnath, Venkataraman ^a   Davies, Sean S ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Cytotoxicity; Endothelial cell; Inflammation; Isoketal; Levuglandin; Oxidative stress; Phosphatidylethanolamine; Phospholipase D

Indexed keywords

ISOKETAL; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; PROSTAGLANDIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CELL LABELING; CELL STRAIN HEK293; CONCENTRATION PROCESS; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; LC 50; LIPID ANALYSIS; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN LIPID INTERACTION; QUANTITATIVE ANALYSIS;

ANIMALS; CELL LINE; CELL SURVIVAL; CYTOTOXINS; ENDOTHELIAL CELLS; HUMANS; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPASE D; PROSTAGLANDINS E; STREPTOMYCES;

EID: 77951072203     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M001040     Document Type: Article

References (30)

1. 2 and novel intramolecular 1,2-hydride shift during endoperoxide fragmentation in aqueous solution. J. Am. Chem. Soc. 106: 6049-6060.
2. Salomon, R. G., and D. B. Miller. 1985. Levuglandins: isolation, characterization, and total synthesis of new secoprostanoid products from prostaglandin endoperoxides. Adv. Prostaglandin Thromboxane Leukot. Res. 15: 323-326.
3. Salomon, R. G., W. Sha, C. Brame, K. Kaur, G. Subbanagounder, J. O'Neil, H. F. Hoff, and L. J. Roberts II. 1999. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein. J. Biol. Chem. 274: 20271-20280.
4. Salomon, R. G., G. Subbanagounder, U. Singh, J. O'Neil, and H. F. Hoff. 1997. Oxidation of low-density lipoproteins produces levuglandin-protein adducts. Chem. Res. Toxicol. 10: 750-759.
5. Brame, C. J., R. G. Salomon, J. D. Morrow, and L. J. Roberts II. 1999. Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts. J. Biol. Chem. 274: 13139-13146.
6. Iyer, R. S., S. Ghosh, and R. G. Salomon. 1989. Levuglandin E2 crosslinks proteins. Prostaglandins. 37: 471-480.
7. DiFranco, E., G. Subbanagounder, S. Kim, K. Murthi, S. Taneda, V. M. Monnier, and R. G. Salomon. 1995. Formation and stability of pyrrole adducts in the reaction of levuglandin E2 with proteins. Chem. Res. Toxicol. 8: 61-67.
8. Salomon, R. G., E. Batyreva, K. Kaur, D. L. Sprecher, M. J. Schreiber, J. W. Crabb, M. S. Penn, A. M. DiCorletoe, S. L. Hazen, and E. A. Podrez. 2000. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. Biochim. Biophys. Acta. 1485: 225-235.
9. Fukuda, K., S. S. Davies, T. Nakajima, B. H. Ong, S. Kupershmidt, J. Fessel, V. Amarnath, M. E. Anderson, P. A. Boyden, P. C. Viswanathan, et al. 2005. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ. Res. 97: 1262-1269.
10. Zagol-Ikapitte, I., T. S. Masterson, V. Amarnath, T. J. Montine, K. I. Andreasson, O. Boutaud, and J. A. Oates. 2005. Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity. J. Neurochem. 94: 1140-1145.
11. Salomon, R. G., G. Subbanagounder, J. O'Neil, K. Kaur, M. A. Smith, H. F. Hoff, G. Perry, and V. M. Monnier. 1997. Levuglandin E2-protein adducts in human plasma and vasculature. Chem. Res. Toxicol. 10: 536-545.
12. Davies, S. S., M. Talati, X. Wang, R. L. Mernaugh, V. Amarnath, J. Fessel, B. O. Meyrick, J. Sheller, and L. J. Roberts II. 2004. Localization of isoketal adducts in vivo using a single-chain antibody. Free Radic. Biol. Med. 36: 1163-1174.
13. Talati, M., B. Meyrick, R. S. Peebles, Jr., S. S. Davies, R. Dworski, R. Mernaugh, D. Mitchell, M. Boothby, L. J. Roberts II, and J. R. Sheller. 2006. Oxidant stress modulates murine allergic airway responses. Free Radic. Biol. Med. 40: 1210-1219.
14. Poliakov, E., M. L. Brennan, J. Macpherson, R. Zhang, W. Sha, L. Narine, R. G. Salomon, and S. L. Hazen. 2003. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo. FASEB J. 17: 2209-2220. (Pubitemid 37509577)
15. Hoppe, G., G. Subbanagounder, J. O'Neil, R. G. Salomon, and H. F. Hoff. 1997. Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid. Biochim. Biophys. Acta. 1344: 1-5.
16. Bernoud-Hubac, N., D. A. Alam, J. Lefils, S. S. Davies, V. Amarnath, M. Guichardant, L. J. Roberts Ii, and M. Lagarde. 2009. Low concentrations of reactive [gamma]-ketoaldehydes prime thromboxane-dependent human platelet aggregation via p38-MAPK activation. Biochim. Biophys. Acta. 1791: 307-313.
17. Brame, C. J., O. Boutaud, S. S. Davies, T. Yang, J. A. Oates, D. Roden, and L. J. Roberts II. 2004. Modification of proteins by isoketal-containing oxidized phospholipids. J. Biol. Chem. 279: 13447-13451.
18. Davies, S. S., V. Amarnath, K. S. Montine, N. Bernoud-Hubac, O. Boutaud, T. J. Montine, and L. J. Roberts II. 2002. Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function. FASEB J. 16: 715-717.
19. Davies, S. S. 2008. Modulation of protein function by isoketals and levuglandins. Subcell. Biochem. 49: 49-70.
20. Amarnath, V., K. Amarnath, K. Amarnath, S. Davies, and L. J. Roberts II. 2004. Pyridoxamine: an extremely potent scavenger of 1,4-dicarbonyls. Chem. Res. Toxicol. 17: 410-415.
21. Bernoud-Hubac, N., L. B. Fay, V. Armarnath, M. Guichardant, S. Bacot, S. S. Davies, L. J. Roberts II, and M. Lagarde. 2004. Covalent binding of isoketals to ethanolamine phospholipids. Free Radic. Biol. Med. 37: 1604-1611.
22. Davies, S. S., E. J. Brantley, P. A. Voziyan, V. Amarnath, I. Zagol- Ikapitte, O. Boutaud, B. G. Hudson, J. A. Oates, and L. J. Roberts II. 2006. Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H(2)O(2)-mediated cytotoxicity. Biochemistry. 45: 15756-15767.
23. Hidalgo, F. J., F. Nogales, and R. Zamora. 2004. Determination of pyrrolized phospholipids in oxidized phospholipid vesicles and lipoproteins. Anal. Biochem. 334: 155-163.
24. Gillum, M. P., D. Zhang, X-M. Zhang, D. M. Erion, R. A. Jamison, C. Choi, J. Dong, M. Shanabrough, H. R. Duenas, D. W. Frederick, et al. 2008. N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake. Cell. 135: 813-824.
25. Shiratsuchi, A., M. Ichiki, Y. Okamoto, N. Ueda, N. Sugimoto, Y. Takuwa, and Y. Nakanishi. 2009. Inhibitory effect of N-palmitoylphosphatidylethanolamine on macrophage phagocytosis through inhibition of Rac1 and Cdc42. J Biochem. 145: 43-50.
26. 2. Synth. Commun. 35: 397-408.
27. Li, W., J. M. Laird, L. Lu, S. Roychowdhury, L. E. Nagy, R. Zhou, J. W. Crabb, and R. G. Salomon. 2009. Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts. Free Radic. Biol. Med. 47: 1539-1552.
28. Carrier, E. J., V. Amarnath, J. A. Oates, and O. Boutaud. 2009. Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin. Biochemistry. 48: 10775-10781.
29. Okamoto, Y., J. Morishita, K. Tsuboi, T. Tonai, and N. Ueda. 2004. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279: 5298-5305.
30. Simon, G. M., and B. F. Cravatt. 2006. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J. Biol. Chem. 281: 26465-26472.